Inflation Reduction Act Reforms Part 2: Changes to Part B and D Drug Benefit Design

In this second part of the three-episode series on the Inflation Reduction Act, host Stephanie Dorvil and guest Joe Metro (Reed Smith, LLP) dig deeper into the IRA’s changes to drug benefit design under Medicare Parts B and D, as well as touch on insulin cost sharing caps. And Joe shares info about a timely opportunity to comment on the inflation rebate provisions before March 11. 

For more information, see Centers for Medicare & Medicaid Services (CMS) Inflation Reduction Act ad Medicare.

• Part 1: Inflation Reduction Act Reforms - An Overview and Discussion of Inflation Rebates
• Part 3: Inflation Reduction Act Reforms - Federal Government Negotiation of Drug Prices